CIK 0000310158 · Large accelerated filer
Merck & Co., Inc.
Sign in to watch- Ticker
- MRK
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NJ
- Entity type
- operating
- EIN
- 221918501
- Phone
- 908-740-4000
- Business address
- 126 EAST LINCOLN AVENUE, P.O. BOX 2000, RAHWAY, NJ, 07065
- Former names
- Merck & Co. Inc., SCHERING PLOUGH CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-06-28 | Coe Mary Ellen Director | Grant or award · Phantom Stock | +242.33 | $123.80 | $30K | 23,169.69 |
| 2024-05-31 | RUSSO PATRICIA F Director | Grant or award · Phantom Stock | +1,752.43 | $125.54 | $220K | 53,951.8 |
| 2024-05-31 | Seidman Christine E Director | Grant or award · Phantom Stock | +1,752.43 | $125.54 | $220K | 14,749.89 |
| 2024-05-31 | Warden Kathy J Director | Grant or award · Phantom Stock | +1,752.43 | $125.54 | $220K | 12,252.5 |
| 2024-05-31 | Rothman Paul Director | Grant or award · Phantom Stock | +1,752.43 | $125.54 | $220K | 28,233.61 |
| 2024-05-31 | THULIN INGE G Director | Grant or award · Phantom Stock | +1,752.43 | $125.54 | $220K | 21,228.92 |
| 2024-05-31 | BAKER DOUGLAS M JR Director | Grant or award · Phantom Stock | +1,752.43 | $125.54 | $220K | 6,281.51 |
| 2024-05-31 | Coe Mary Ellen Director | Grant or award · Phantom Stock | +1,752.43 | $125.54 | $220K | 22,927.36 |
| 2024-05-31 | Craig Pamela J. Director | Grant or award · Phantom Stock | +1,752.43 | $125.54 | $220K | 28,233.6 |
| 2024-05-31 | GLOCER THOMAS H Director | Grant or award · Phantom Stock | +1,752.43 | $125.54 | $220K | 95,669.36 |
| 2024-05-31 | Mayo Stephen Director | Grant or award · Phantom Stock | +1,752.43 | $125.54 | $220K | 9,379.7 |
| 2024-05-31 | LAVIZZO-MOUREY RISA J Director | Grant or award · Phantom Stock | +1,752.43 | $125.54 | $220K | 12,120.43 |
| 2024-05-04 | Smart Dalton SVP Fin. - Global Controller | Option exercise | +612 | $127.51 | $78K | 4,730.29 |
| 2024-05-04 | Smart Dalton SVP Fin. - Global Controller | Shares withheld for taxes | −302 | $127.51 | $39K | 4,428.29 |
| 2024-05-04 | Smart Dalton SVP Fin. - Global Controller | Option exercise · Restricted Stock Unit | −612 | 0 | ||
| 2024-05-04 | DeLuca Richard R. EVP&Pres, Merck Animal Heallth | Option exercise | +27,126 | $127.51 | $3.5M | 163,719.56 |
| 2024-05-04 | DeLuca Richard R. EVP&Pres, Merck Animal Heallth | Shares withheld for taxes | −13,360 | $127.51 | $1.7M | 150,359.56 |
| 2024-05-04 | DeLuca Richard R. EVP&Pres, Merck Animal Heallth | Option exercise · Restricted Stock Unit | −27,126 | 0 | ||
| 2024-05-04 | Klobuchar Michael A EVP - Chief Strategy Officer | Option exercise | +887 | $127.51 | $113K | 24,058.2 |
| 2024-05-04 | Klobuchar Michael A EVP - Chief Strategy Officer | Shares withheld for taxes | −437 | $127.51 | $56K | 23,621.2 |
Page 15 of 19 · 376 trades